(Q31893384)

English

A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of [...]

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

fludarabine phosphate

1 reference

based on heuristic

inferred from title

refractory anemia

1 reference

based on heuristic

inferred from title

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

G Jackson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Taylor

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G M Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Marcus

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Chu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T J Littlewood

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Duncombe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Hutchinson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A B Mehta

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S A Johnson

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Carey

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M J MacKie

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G E Turner

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Deane

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Schey

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Brookes

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S M Tollerfield

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M P Wilson

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

127-137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Results of Therapy for Acute Myeloid Leukemia in First Relapse

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02551.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02551.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

release_hstgxhlc6jcmnhlegs5qnv5ypa

1 reference

https://api.fatcat.wiki/v0/release/hstgxhlc6jcmnhlegs5qnv5ypa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167793%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31893384&oldid=1975978999"